At Keros, our mission is to deliver significant clinical benefit to a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (TGF-ß) family of proteins. With a focus on developing differentiated product candidates that are designed to alter TGF-β signaling, we aim to target the pathways critical for the growth, repair and maintenance of blood cells and a number of tissues, including bone, skeletal muscle, adipose and heart tissue. We believe our product candidates have the potential to unlock the full therapeutic benefits of modulating the TGF-β superfamily and provide disease-modifying benefit to patients. Job Summary This role will focus on the design, development, and successful transfer of cell-based and ligand-binding potency assays to support the characterization, release, and stability testing of Keros’ pre-clinical and clinical phase products. The ideal candidate will have deep expertise in potency and bioassay development with strong analytical skills that can be applied across other areas of analytical development. The candidate will collaborate effectively within cross-functional teams, including colleagues from Research, Quality Control, Process Development, and MSAT to promote successful transfer of analytical release assays to CDMO’s.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Education Level
Ph.D. or professional degree
Number of Employees
101-250 employees